Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 6,626 shares at $113.76 ($770K) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Seasonal sale ($770k) by Chief Research Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.76 | 605 | $69K | 8.9% |
| 2 | $113.76 | 605 | $69K | 8.9% |
| 3 | $116.67 | 687 | $80K | 10.4% |
| 4 | $116.67 | 687 | $80K | 10.4% |
| 5 | $116.69 | 803 | $94K | 12.2% |
| 6 | $116.69 | 803 |
| $94K |
| 12.2% |
| 7 | $116.70 | 1,218 | $142K | 18.5% |
| 8 | $116.70 | 1,218 | $142K | 18.5% |
| Total | $116.15 avg | 6,626 | $770K | 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |
| NBIX | SELL | 2020-05-11 | $1.8M | — | Filing → |